Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Feb-24 9:50 PM View:  | Better Therapeutics, Inc. (BTTX) | 09-Feb-24 | Grant | 839,895 | $0.19 | $160,000.00 | 5% 18.56M to 19.4M | |
| 10-Jan-24 4:19 PM View: | Better Therapeutics, Inc. (BTTX) | 09-Jan-24 | Grant | 1,471,450 | $0.17 | $250,000.00 | 9% 17.09M to 18.56M | |
| 20-Dec-23 5:24 PM View: | Better Therapeutics, Inc. (BTTX) | 18-Dec-23 | Grant | 3,750 | -- | -- | < 1% 17.08M to 17.09M | |
| 31-Jul-23 7:59 AM View: | Better Therapeutics, Inc. (BTTX) | 27-Jul-23 | Purchase | 1,233,040 | $0.73 | $900,000.00 | 8% 15.85M to 17.08M | |
| 12-Apr-23 9:44 PM View: | Better Therapeutics, Inc. (BTTX) | 10-Apr-23 | Purchase | 4,969,700 | $0.82 | $4,100,000.00 | 46% 10.88M to 15.85M | |
| 19-Sep-22 6:06 AM View: | Better Therapeutics, Inc. (BTTX) | 16-Sep-22 | Purchase | 39,156 | $2.07 | $80,974.60 | < 1% 10.84M to 10.88M | |
| 19-Sep-22 6:06 AM View: | Better Therapeutics, Inc. (BTTX) | 15-Sep-22 | Purchase | 10,844 | $1.99 | $21,622.90 | < 1% 10.83M to 10.84M | |
| 06-Mar-14 6:16 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 05-Mar-14 | Market Sale (Planned) | 7,500 | $20.24 | $151,814.00 | (2%) 368.81K to 361.31K | (251%) |
| 06-Mar-14 6:16 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 04-Mar-14 | Market Sale | 50,000 | $20.22 | $1,011,080.00 | (12%) 426.31K to 376.31K | (251%) |
| 06-Mar-14 6:16 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 04-Mar-14 | Market Sale (Planned) | 7,500 | $20.20 | $151,503.00 | (2%) 376.31K to 368.81K | (251%) |
| 05-Feb-14 7:30 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 05-Feb-14 | Market Sale (Planned) | 7,500 | $16.71 | $125,303.00 | (2%) 433.81K to 426.31K | (325%) |
| 05-Feb-14 7:30 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 04-Feb-14 | Market Sale (Planned) | 7,500 | $17.29 | $129,704.00 | (2%) 441.31K to 433.81K | (310%) |
| 09-Jan-14 6:27 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 09-Jan-14 | Market Sale (Planned) | 7,500 | $16.49 | $123,652.00 | (2%) 448.81K to 441.31K | (330%) |
| 09-Jan-14 6:27 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 08-Jan-14 | Market Sale (Planned) | 57,500 | $16.30 | $937,454.00 | (11%) 506.31K to 448.81K | (335%) |
| 09-Dec-13 7:55 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 09-Dec-13 | Option Exercise | 285,480 | $0.60 | $171,288.00 | 124% 231.15K to 516.63K | |
| 09-Dec-13 7:55 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 09-Dec-13 | Market Option Sale | 10,328 | $16.72 | $172,717.00 | (2%) 516.63K to 506.31K | (324%) |
| 09-Dec-13 7:55 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 06-Dec-13 | Market Option Sale (Planned) | 15,000 | $16.85 | $252,699.00 | (6%) 246.15K to 231.15K | (321%) |
| 09-Dec-13 7:55 PM View: | Anacor Pharmaceuticals, Inc. (ANAC) | 05-Dec-13 | Market Sale (Planned) | 15,000 | $15.28 | $229,171.00 | (6%) 261.15K to 246.15K | (364%) |